Literature DB >> 8646053

Screening asymptomatic people at high risk for hepatitis C. The case against.

M C Allison1, P R Mills.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8646053      PMCID： PMC2350998          DOI： 10.1136/bmj.312.7042.1349

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  14 in total

1.  Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships.

Authors:  D L Thomas; J M Zenilman; H J Alter; J W Shih; N Galai; A V Carella; T C Quinn
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

Review 2.  Role of sigmoidoscopy in screening for colorectal cancer: a critical review.

Authors:  A I Neugut; S Pita
Journal:  Gastroenterology       Date:  1988-08       Impact factor: 22.682

Review 3.  Epidemiology of hepatitis C in the West.

Authors:  M J Alter
Journal:  Semin Liver Dis       Date:  1995-02       Impact factor: 6.115

4.  Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.

Authors:  A M Di Bisceglie; Z D Goodman; K G Ishak; J H Hoofnagle; J J Melpolder; H J Alter
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

5.  The declining risk of post-transfusion hepatitis C virus infection.

Authors:  J G Donahue; A Muñoz; P M Ness; D E Brown; D H Yawn; H A McAllister; B A Reitz; K E Nelson
Journal:  N Engl J Med       Date:  1992-08-06       Impact factor: 91.245

6.  Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group.

Authors:  L B Seeff; Z Buskell-Bales; E C Wright; S J Durako; H J Alter; F L Iber; F B Hollinger; G Gitnick; R G Knodell; R P Perrillo
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

7.  Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis.

Authors:  F Tremolada; C Casarin; A Alberti; C Drago; A Tagger; M L Ribero; G Realdi
Journal:  J Hepatol       Date:  1992-11       Impact factor: 25.083

8.  A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

Authors:  T Poynard; P Bedossa; M Chevallier; P Mathurin; C Lemonnier; C Trepo; P Couzigou; J L Payen; M Sajus; J M Costa
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

9.  Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission.

Authors:  A R Zanetti; E Tanzi; S Paccagnini; N Principi; G Pizzocolo; M L Caccamo; E D'Amico; G Cambiè; L Vecchi
Journal:  Lancet       Date:  1995-02-04       Impact factor: 79.321

10.  The pathology of hepatitis C as a function of mode of transmission: blood transfusion vs. intravenous drug use.

Authors:  S C Gordon; R S Elloway; J C Long; C F Dmuchowski
Journal:  Hepatology       Date:  1993-12       Impact factor: 17.425
View more
  3 in total

1.  Alanine aminotransferase assay to detect anti-HCV positive subjects in non-selected populations.

Authors:  V Guadagnino; T Stroffolini; M Rapicetta; E Gulletta
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

2.  Assessment of hepatitis C infection in injecting drug users attending an addiction treatment clinic.

Authors:  B P Smyth; E Keenan; J J O'Connor
Journal:  Ir J Med Sci       Date:  2000 Apr-Jun       Impact factor: 1.568

3.  Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees.

Authors:  V Sypsa; E Hadjipaschali; A Hatzakis
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.